Polycef

For oral administration. The dry powder should be reconstituted with boiled and cooled water according to the manufacturer's instructions. Shake the bottle well before each use. Administer the prescribed dose using the provided calibrated dropper, with or without food.

Cefradine acts by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located in the bacterial cell wall, which prevents the cross-linking of peptidoglycan chains, leading to a defective and unstable cell wall, ultimately resulting in bacterial cell lysis and death.

• Known hypersensitivity to cefradine, other cephalosporins, or to any component of the formulation.
• History of severe hypersensitivity reactions (e.g., anaphylaxis) to penicillins or other beta-lactam antibiotics.

Store the dry powder below 30°C in a cool, dry place, protected from light and moisture. Store the reconstituted suspension in a refrigerator (2-8°C). Do not freeze. Keep out of reach of children.

Symptoms of overdose may include nausea, vomiting, diarrhea, epigastric distress, and occasionally convulsions (especially in patients with renal impairment). Management involves symptomatic and supportive care. Hemodialysis may be useful in accelerating the removal of cefradine from the blood.

Pregnancy Category B. Studies in animals have shown no evidence of harm to the fetus. However, there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed. Small amounts of cefradine are excreted in human milk. Caution should be exercised when cefradine is administered to a nursing woman.

• Known hypersensitivity to cefradine, other cephalosporins, or to any component of the formulation.
• History of severe hypersensitivity reactions (e.g., anaphylaxis) to penicillins or other beta-lactam antibiotics.

Store the dry powder below 30°C in a cool, dry place, protected from light and moisture. Store the reconstituted suspension in a refrigerator (2-8°C). Do not freeze. Keep out of reach of children.

Symptoms of overdose may include nausea, vomiting, diarrhea, epigastric distress, and occasionally convulsions (especially in patients with renal impairment). Management involves symptomatic and supportive care. Hemodialysis may be useful in accelerating the removal of cefradine from the blood.

Pregnancy Category B. Studies in animals have shown no evidence of harm to the fetus. However, there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed. Small amounts of cefradine are excreted in human milk. Caution should be exercised when cefradine is administered to a nursing woman.